Other featured articles
Health Technology Assessment for the U.S. Healthcare System
A white paper from the USC Schaeffer Center-Aspen Institute Advisory Panel on health technology assessment in the U.S. Experts explore how to better link the price of health technologies to the benefits they provide to patients while ensuring a sustainable healthcare ecosystem that supports innovation.
The Association Between Drug Rebates and List Prices
Drug rebates and list prices are positively correlated: On average, a $1 increase in rebates is associated with a $1.17 increase in list price.
Georgia’s 1332 Waiver Violates the ACA and Cannot Lawfully be Approved
Christen Linke Young and Jason Levitis explain why Georgia’s 1332 waiver would fail the affordability guardrail and is based on several assumptions.
Hospital System Participation and Hospital Spending
Schaeffer Center researchers found that most hospital systems span across markets and states with higher system participation were more likely to have below median per capita hospital spending. Their work suggests that researchers and policymakers should consider hospital system membership separately from market concentration.